Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium for acid-associated heartburn symptoms
NCT00206024Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2004
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Nov 2004; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00206024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206024.